TScan Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
TScan Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
  • TScan Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -1.28K %, a 138% decline year-over-year.
  • TScan Therapeutics, Inc. annual Operating Margin for 2023 was -444 %, a 9.82% increase from 2022.
  • TScan Therapeutics, Inc. annual Operating Margin for 2022 was -492 %, a 2.64% decline from 2021.
  • TScan Therapeutics, Inc. annual Operating Margin for 2021 was -480 %, a 80.2% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -1.28K -740 -138% Jul 1, 2024 Sep 30, 2024
Q2 2024 -915 -411 -81.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -689 -266 -63% Jan 1, 2024 Mar 31, 2024
Q4 2023 -444 +48.3 +9.82% Oct 1, 2023 Dec 31, 2023
Q3 2023 -536 -68.1 -14.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -503 -5.38 -1.08% Apr 1, 2023 Jun 30, 2023
Q1 2023 -423 +88.1 +17.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -492 -12.7 -2.64% Oct 1, 2022 Dec 31, 2022
Q3 2022 -468 Jul 1, 2022 Sep 30, 2022
Q2 2022 -498 Apr 1, 2022 Jun 30, 2022
Q1 2022 -511 Jan 1, 2022 Mar 31, 2022
Q4 2021 -480 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.